- Home
- / C.Q. Pharmaceutical Holding
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
C.Q. Pharmaceutical Holding financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥5.4
2024-10-29
Market Capitalization
¥9.3 B
2024-10-29
Revenue
¥81.8 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 25.6B | 33.6B | 45.0B | 62.2B | 67.5B | 79.6B | 80.1B | 81.8B |
| Cost of goods sold | 23.5B | 30.8B | 41.0B | 56.8B | 62.0B | 73.8B | 74.6B | 76.5B |
| Gross profit | 2.2B | 3.0B | 4.1B | 5.6B | 5.6B | 6.1B | 5.8B | 5.7B |
| Gross profit margin, % | 8.7% | 8.8% | 9.1% | 9.0% | 8.3% | 7.6% | 7.2% | 7.0% |
| Operating expense total | 1.5B | 1.8B | 2.2B | 3.1B | 3.4B | 3.7B | 4.1B | 4.1B |
| Depreciation and amortization | 72.8M | 128.8M | 315.4M | 259.4M | 258.6M | 299.5M | 328.8M | 296.3M |
| EBITDA | 998.8M | 1.4B | 2.2B | 2.7B | 2.5B | 2.7B | 2.1B | 2.1B |
| EBITDA margin, % | 3.9% | 4.3% | 4.8% | 4.4% | 3.8% | 3.4% | 2.6% | 2.6% |
| EBIT | 848.8M | 1.3B | 1.8B | 2.4B | 2.3B | 2.0B | 1.2B | 994.5M |
| EBIT margin, % | 3.3% | 3.8% | 4.0% | 3.8% | 3.4% | 2.5% | 1.5% | 1.2% |
| Interest income | 24.4M | 22.9M | 37.1M | 45.2M | 61.9M | 91.7M | 85.8M | 61.0M |
| Interest expense | 187.3M | 432.0M | 675.5M | 1.1B | 1.1B | 1.3B | 1.1B | 758.3M |
| Pre tax profit | 853.9M | 1.1B | 1.4B | 1.6B | 1.5B | 1.0B | 557.5M | 671.9M |
| Income tax expense | 103.0M | 173.3M | 227.1M | 289.6M | 309.5M | 236.0M | 155.7M | 150.5M |
| Net Income | 750.9M | 944.3M | 1.1B | 1.3B | 1.2B | 772.5M | 401.8M | 521.3M |